Juan
Clofent Villaplana
Investigador ata 2013
Hospital de Sagunto
Sagunto, EspañaPublicacións en colaboración con investigadores/as de Hospital de Sagunto (11)
2020
-
Retrospective cohort study: Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test
World Journal of Gastroenterology, Vol. 26, Núm. 1, pp. 70-85
2019
-
High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome
Endoscopy, Vol. 51, Núm. 2, pp. 142-151
2018
-
Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update
Gastroenterologia y Hepatologia, Vol. 41, Núm. 9, pp. 585-596
2016
-
Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC)
Carcinogenesis, Vol. 37, Núm. 8, pp. 751-758
-
Colorectal cancer risk factors in patients with serrated polyposis syndrome: A large multicentre study
Gut, Vol. 65, Núm. 11, pp. 1829-1837
-
Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients
BMC Medicine, Vol. 14, Núm. 1
2014
-
High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families
Clinical Genetics, Vol. 85, Núm. 6, pp. 583-588
2013
-
Risk of cancer in cases of suspected lynch syndrome without germline mutation
Gastroenterology, Vol. 144, Núm. 5
2012
-
Intestinal cancer in inflammatory bowel disease: Natural history and surveillance guidelines
Annals of Gastroenterology, Vol. 25, Núm. 3, pp. 193-203
-
Protocolo para la monitorización de la terapia inmunosupresora y biológica en una unidad de atención integral a pacientes con enfermedad inflamatoria intestinal
Gastroenterologia y Hepatologia, Vol. 35, Núm. 8, pp. 602-607
2007
-
Crohn's disease: A review of current treatment with a focus on biologics
Drugs, Vol. 67, Núm. 17, pp. 2511-2537